Brazilian Protocol for Sexually Transmitted Infections, 2020: congenital syphilis and child exposed to syphilis.

The topics of congenital syphilis and children exposed to syphilis compose the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health in 2020. Such document was elaborated based on scientific evidence and validated in discussions with specialists. This article provides guidelines for syphilis in pregnant women and congenital syphilis clinical management, emphasizing the vertical transmission of Treponema pallidum prevention. Epidemiological and clinical aspects of these infections are presented and recommendations for managers in the programmatic and operational management of syphilis. The article also includes guidelines for health professionals in screening, diagnosing, and treating people with sexually transmitted infections and their sex partners, in addition to strategies for surveillance actions, prevention, and control of the disease. Most congenital syphilis cases arise from test failures in prenatal care or inadequate or no treatment of maternal syphilis.

[Brazilian Protocol for Sexually Transmitted Infections 2020: congenital syphilis and child exposed to syphilis]. / Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: sífilis congênita e criança exposta à sífilis.

The topics of congenital syphilis and children exposed to syphilis are part of the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health in 2020. The Protocol and Guidelines have been developed based on scientific evidence and validated in discussions with specialists. This article provides guidelines for clinical management of both syphilis in pregnant women and also congenital syphilis, emphasizing prevention of vertical transmission of Treponema pallidum. Epidemiological and clinical aspects of these infections are presented, as well as recommendations for health service managers regarding the programmatic and operational management of syphilis. The article also includes guidelines for health professionals on screening, diagnosing and treating people with sexually transmitted infections and their sex partners, in addition to strategies for syphilis surveillance, prevention and control actions.

Os temas sífilis congênita e criança exposta à sífilis compõem o Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis, publicado pelo Ministério da Saúde do Brasil em 2020. Tal documento foi elaborado com base em evidências científicas e validado em discussões com especialistas. Este artigo apresenta orientações para o manejo clínico da sífilis em gestantes e da sífilis congênita, enfatizando a prevenção da transmissão vertical do Treponema pallidum. Nele estão contemplados aspectos epidemiológicos e clínicos desses agravos, bem como recomendações aos gestores no manejo programático e operacional da sífilis. Também se incluem orientações para os profissionais de saúde na triagem, diagnóstico e tratamento das pessoas com infecções sexualmente transmissíveis e suas parcerias sexuais, além de estratégias para ações de vigilância, prevenção e controle da doença.

Los temas sífilis congénita y niños expuestos a la sífilis componen el Protocolo Clínico y Directrices Terapéuticas para la Atención Integral a Personas con Infecciones de Transmisión Sexual, publicado por el Ministerio de Salud de Brasil en 2020. Tal documento fue elaborado con base en evidencia científica y validado en discusiones con especialistas. Este artículo presenta directrices para el manejo clínico de la sífilis en mujeres embarazadas y de la sífilis congénita, con énfasis en la prevención de la transmisión vertical del Treponema pallidum. Se contemplan aspectos epidemiológicos y clínicos de la infección, así como recomendaciones para gestores en la gestión programática y operativa de la sífilis. También se incluyen directrices para profesionales de la salud en la detección, diagnóstico y tratamiento de personas con infecciones de transmisión sexual y sus parejas sexuales, además de estrategias para acciones de vigilancia, prevención y control de la enfermedad.

Brazilian Protocol for Sexually Transmitted Infections, 2020: congenital syphilis and child exposed to syphilis

Abstract The topics of congenital syphilis and children exposed to syphilis compose the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health in 2020. Such document was elaborated based on scientific evidence and validated in discussions with specialists. This article provides guidelines for syphilis in pregnant women and congenital syphilis clinical management, emphasizing the vertical transmission of Treponema pallidum prevention. Epidemiological and clinical aspects of these infections are presented and recommendations for managers in the programmatic and operational management of syphilis. The article also includes guidelines for health professionals in screening, diagnosing, and treating people with sexually transmitted infections and their sex partners, in addition to strategies for surveillance actions, prevention, and control of the disease.

Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: sífilis congênita e criança exposta à sífilis / Brazilian Protocol for Sexually Transmitted Infections 2020: congenital syphilis and child exposed to syphilis / Protocolo Brasileño para Infecciones de Transmisión Sexual 2020: sífilis congénita y niño expuesto a la sífilis

Os temas sífilis congênita e criança exposta à sífilis compõem o Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis, publicado pelo Ministério da Saúde do Brasil em 2020. Tal documento foi elaborado com base em evidências científicas e validado em discussões com especialistas. Este artigo apresenta orientações para o manejo clínico da sífilis em gestantes e da sífilis congênita, enfatizando a prevenção da transmissão vertical do Treponema pallidum. Nele estão contemplados aspectos epidemiológicos e clínicos desses agravos, bem como recomendações aos gestores no manejo programático e operacional da sífilis. Também se incluem orientações para os profissionais de saúde na triagem, diagnóstico e tratamento das pessoas com infecções sexualmente transmissíveis e suas parcerias sexuais, além de estratégias para ações de vigilância, prevenção e controle da doença.

The topics of congenital syphilis and children exposed to syphilis are part of the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health in 2020. The Protocol and Guidelines have been developed based on scientific evidence and validated in discussions with specialists. This article provides guidelines for clinical management of both syphilis in pregnant women and also congenital syphilis, emphasizing prevention of vertical transmission of Treponema pallidum. Epidemiological and clinical aspects of these infections are presented, as well as recommendations for health service managers regarding the programmatic and operational management of syphilis. The article also includes guidelines for health professionals on screening, diagnosing and treating people with sexually transmitted infections and their sex partners, in addition to strategies for syphilis surveillance, prevention and control actions.

Los temas sífilis congénita y niños expuestos a la sífilis componen el Protocolo Clínico y Directrices Terapéuticas para la Atención Integral a Personas con Infecciones de Transmisión Sexual, publicado por el Ministerio de Salud de Brasil en 2020. Tal documento fue elaborado con base en evidencia científica y validado en discusiones con especialistas. Este artículo presenta directrices para el manejo clínico de la sífilis en mujeres embarazadas y de la sífilis congénita, con énfasis en la prevención de la transmisión vertical del Treponema pallidum. Se contemplan aspectos epidemiológicos y clínicos de la infección, así como recomendaciones para gestores en la gestión programática y operativa de la sífilis. También se incluyen directrices para profesionales de la salud en la detección, diagnóstico y tratamiento de personas con infecciones de transmisión sexual y sus parejas sexuales, además de estrategias para acciones de vigilancia, prevención y control de la enfermedad.

Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: sífilis congênita e criança exposta à sífilis / Brazilian Protocol for Sexually Transmitted Infections 2020: congenital syphilis and child exposed to syphilis / Protocolo Brasileño para Infecciones de Transmisión Sexual 2020: sífilis congénita y niño expuesto a la sífilis

Os temas sífilis congênita e criança exposta à sífilis compõem o Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis, publicado pelo Ministério da Saúde do Brasil em 2020. Tal documento foi elaborado com base em evidências científicas e validado em discussões com especialistas. Este artigo apresenta orientações para o manejo clínico da sífilis em gestantes e da sífilis congênita, enfatizando a prevenção da transmissão vertical do Treponema pallidum. Nele estão contemplados aspectos epidemiológicos e clínicos desses agravos, bem como recomendações aos gestores no manejo programático e operacional da sífilis. Também se incluem orientações para os profissionais de saúde na triagem, diagnóstico e tratamento das pessoas com infecções sexualmente transmissíveis e suas parcerias sexuais, além de estratégias para ações de vigilância, prevenção e controle da doença.

The topics of congenital syphilis and children exposed to syphilis are part of the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health in 2020. The Protocol and Guidelines have been developed based on scientific evidence and validated in discussions with specialists. This article provides guidelines for clinical management of both syphilis in pregnant women and also congenital syphilis, emphasizing prevention of vertical transmission of Treponema pallidum. Epidemiological and clinical aspects of these infections are presented, as well as recommendations for health service managers regarding the programmatic and operational management of syphilis. The article also includes guidelines for health professionals on screening, diagnosing and treating people with sexually transmitted infections and their sex partners, in addition to strategies for syphilis surveillance, prevention and control actions.

Los temas sífilis congénita y niños expuestos a la sífilis componen el Protocolo Clínico y Directrices Terapéuticas para la Atención Integral a Personas con Infecciones de Transmisión Sexual, publicado por el Ministerio de Salud de Brasil en 2020. Tal documento fue elaborado con base en evidencia científica y validado en discusiones con especialistas. Este artículo presenta directrices para el manejo clínico de la sífilis en mujeres embarazadas y de la sífilis congénita, con énfasis en la prevención de la transmisión vertical del Treponema pallidum. Se contemplan aspectos epidemiológicos y clínicos de la infección, así como recomendaciones para gestores en la gestión programática y operativa de la sífilis. También se incluyen directrices para profesionales de la salud en la detección, diagnóstico y tratamiento de personas con infecciones de transmisión sexual y sus parejas sexuales, además de estrategias para acciones de vigilancia, prevención y control de la enfermedad.

Influence of Religiosity on Situational Coping Scores in Women with Malformed Fetuses.

In clinical care settings, religiosity may serve as an important source of support for coping with the prenatal diagnosis of fetal abnormalities. This study evaluated the influence of religiosity on the situational coping of 28 pregnant women with fetal abnormalities. The study was approved by the institutional research ethics committee, and the informed consent document was obtained from all participants included in this study. Validated measures of religiosity and situational coping were used to evaluate data collected. Practical religiosity but not intrinsic religiosity correlated positively and significantly with coping scores. However, the severity of the fetal malformations did not correlate significantly with the scores of maternal coping. The results showed that religious practices were associated with improved coping in women diagnosed with fetal abnormalities and should be encouraged in care settings.

Epidemiological Risk Factors and Perinatal Outcomes of Congenital Anomalies.

Objectives To identify the epidemiological risk factors for congenital anomalies (CAs) and the impact of these fetal malformations on the perinatal outcomes. Methods This prospective cohort study comprised 275 women whose fetuses had CAs. Maternal variables to establish potential risk factors for each group of CA and perinatal outcomes were evaluated. The primary outcome was CA. Secondary outcomes included: fetal growth restriction (FGR); fetal distress (FD); premature rupture of membranes (PROM); oligohydramnios or polyhydramnios; preterm delivery (PTD); stillbirth; cesarean section; low birth weight; Apgar score < 7 at the 1st and 5th minutes; need for assisted ventilation at birth; neonatal infection; need for surgical treatment; early neonatal death; and hospitalization time. Chi-square (χ(2)) test and multilevel regression analysis were applied to compare the groups and determine the effects of maternal characteristics on the incidence of CAs. Results The general prevalence of CAs was of 2.4%. Several maternal characteristics were associated to CAs, such as: age; skin color; level of education; parity; folic acid supplementation; tobacco use; and history of previous miscarriage. There were no significant differences among the CA groups in relation to FGR, FD, PROM, 1-minute Apgar score > 7, and need for assisted ventilation at birth. On the other hand, the prevalence of the other considered outcomes varied significantly among groups. Preterm delivery was significantly more frequent in gastrointestinal tract/abdominal wall defects. The stillbirth rate was increased in all CAs, mainly in isolated fetal hydrops (odds ratio [OR]: 27.13; 95% confidence interval [95%CI]: 2.90-253.47). Hospitalization time was higher for the urinary tract and congenital heart disease groups (p < 0.01). Neonatal death was significantly less frequent in the central nervous system anomalies group. Conclusion It was possible to identify several risk factors for CAs. Adverse perinatal outcomes were presented in all CA groups, and may differ according to the type of CA considered.

Epidemiological Risk Factors and Perinatal Outcomes of Congenital Anomalies / Fatores de risco epidemiológicos e resultados perinatais das anomalias congênitas

Abstract Objectives To identify the epidemiological risk factors for congenital anomalies (CAs) and the impact of these fetal malformations on the perinatal outcomes. Methods This prospective cohort study comprised 275 women whose fetuses had CAs. Maternal variables to establish potential risk factors for each group of CA and perinatal outcomes were evaluated. The primary outcome was CA. Secondary outcomes included: fetal growth restriction (FGR); fetal distress (FD); premature rupture of membranes (PROM); oligohydramnios or polyhydramnios; preterm delivery (PTD); stillbirth; cesarean section; low birth weight; Apgar score < 7 at the 1st and 5th minutes; need for assisted ventilation at birth; neonatal infection; need for surgical treatment; early neonatal death; and hospitalization time. Chi-square (x2) test and multilevel regression analysis were applied to compare the groups and determine the effects of maternal characteristics on the incidence of CAs. Results The general prevalence of CAs was of 2.4%. Several maternal characteristics were associated to CAs, such as: age; skin color; level of education; parity; folic acid supplementation; tobacco use; and history of previous miscarriage. There were no significant differences among the CA groups in relation to FGR, FD, PROM, 1-minute Apgar score > 7, and need for assisted ventilation at birth. On the other hand, the prevalence of the other considered outcomes varied significantly among groups. Preterm delivery was significantly more frequent in gastrointestinal tract/abdominal wall defects. The stillbirth rate was increased in all CAs, mainly in isolated fetal hydrops (odds ratio [OR]: 27.13; 95% confidence interval [95%CI]: 2.90-253.47). Hospitalization time was higher for the urinary tract and congenital heart disease groups (p < 0.01). Neonatal death was significantly less frequent in the central nervous system anomalies group. Conclusion It was possible to identify several risk factors for CAs. Adverse perinatal outcomes were presented in all CA groups, and may differ according to the type of CA considered.

Resumo Objetivos Identificar os fatores epidemiológicos de risco para anomalias congênitas (ACs) e o impacto destas malformações fetais sobre os resultados perinatais. Métodos Este estudo de coorte prospectivo compreendeu 275 mulheres cujos fetos tinham ACs. Variáveis maternas para estabelecer potenciais fatores de risco para cada grupo de AC e resultados perinatais foram avaliados. O desfecho primário foi CAs. Os desfechos secundários incluíram: restrição de crescimento fetal (RCF); sofrimento fetal (SF); ruptura prematura de membranas (RPM); oligo-hidrâmnio ou polidrâmnio; parto pré-termo (PPT); morte fetal; parto cesárea; baixo peso ao nascer; índice de Apgar < 7 no 1° e 5° minutos; necessidade de ventilação assistida no momento do nascimento; infecção neonatal; necessidade de tratamento cirúrgico; óbito neonatal precoce; e tempo de internação. Teste de Qui-quadrado (x2) e análise de regressãomúltipla foram aplicados para comparar os resultados entre os grupos e determinar os efeitos das características maternas sobre a incidência de ACs. Resultados A prevalência geral de ACs foi de 2.4%. Várias características maternas foram associadas às ACs, tais como: idade; cor da pele; escolaridade; paridade; suplementação com ácido fólico; tabagismo; e histórico de aborto anterior. Não houve diferenças significativas entre os grupos de ACs com relação à RCF, SF, RPM, índice de Apgar < 7 no 1°minuto e necessidade de ventilação assistida no nascimento. Por outro lado, a prevalência dos demais resultados adversos considerados variou significativamente entre os grupos. O parto pré-termo foi significativamente mais frequente nos casos de defeitos do trato gastrointestinal/parede abdominal. As taxas de óbito fetal foram elevadas em todos os grupos de ACs, principalmente na hidropsia fetal isolada (odds ratio [OR]: 27.13; intervalo de confiança de 95% [IC95%]: 2.90-253.47). O tempo de internação foi maior nos casos de anomalias do trato urinário e nas cardiopatias congênitas (p < 0,01). O óbito neonatal foi significativamente menos frequente no grupo de anomalias do sistema nervoso central. Conclusão Foi possível identificar vários fatores de risco para ACs. Resultados perinatais adversos foram observados em todos os grupos de ACs, e podem diferir de acordo com o tipo de AC considerada.

Transcutaneous electrical nerve stimulation (TENS) reduces pain and postpones the need for pharmacological analgesia during labour: a randomised trial.

QUESTIONS: In the active phase of the first stage of labour, does transcutaneous electrical nerve stimulation (TENS) relieve pain or change its location? Does TENS delay the request for neuraxial analgesia during labour? Does TENS produce any harmful effects in the mother or the foetus? Are women in labour satisfied with the care provided? DESIGN: Randomised trial with concealed allocation, assessor blinding for some outcomes, and intention-to-treat analysis. PARTICIPANTS: Forty-six low-risk, primigravida parturients with a gestational age > 37 weeks, cervical dilation of 4cm, and without the use of any medications from hospital admission until randomisation. INTERVENTION: The principal investigator applied TENS to the experimental group for 30minutes starting at the beginning of the active phase of labour. A second investigator assessed the outcomes in both the control and experimental groups. Both groups received routine perinatal care. OUTCOME MEASURES: The primary outcome was pain severity after the intervention period, which was assessed using the 100-mm visual analogue scale. Secondary outcomes included: pain location, duration of the active phase of labour, time to pharmacological labour analgesia, mode of birth, neonatal outcomes, and the participant's satisfaction with the care provided. RESULTS: After the intervention, a significant mean difference in change in pain of 15mm was observed favouring the experimental group (95% CI 2 to 27). The application of TENS did not alter the location or distribution of the pain. The mean time to pharmacological analgesia after the intervention was 5.0hours (95% CI 4.1 to 5.9) longer in the experimental group. The intervention did not significantly impact the other maternal and neonatal outcomes. Participants in both groups were satisfied with the care provided during labour. CONCLUSION: TENS produces a significant decrease in pain during labour and postpones the need for pharmacological analgesia for pain relief. TRIAL REGISTRATION: NCT01600495.

Massage reduced severity of pain during labour: a randomised trial.

QUESTION: Does massage relieve pain in the active phase of labour? DESIGN: Randomised trial with concealed allocation, assessor blinding for some outcomes, and intention-to-treat analysis. PARTICIPANTS: 46 women pregnant at ≥ 37 weeks gestation with a single fetus, with spontaneous onset of labour, 4-5cm of cervical dilation, intact ovular membranes, and no use of medication after admission to hospital. INTERVENTION: Experimental group participants received a 30-min lumbar massage by a physiotherapist during the active phase of labour. A physiotherapist attended control group participants for the same period but only answered questions. Both groups received routine perinatal care. OUTCOME MEASURES: The primary outcome was pain severity measured on a 100mm visual analogue scale. Secondary outcomes included the Short Form McGill Pain Questionnaire, pain location, and time to analgesic medication use. After labour, a blinded researcher also recorded duration of labour, route of delivery, neonatal outcomes, and the participant's satisfaction with the physiotherapist during labour. RESULTS: At the end of the intervention, pain severity was 52mm (SD 20) in the experimental group and 72mm (SD 15) in control group, which was significantly different with a mean difference of 20mm (95% CI 10 to 31). The groups did not differ significantly on the other pain-related outcome measures. Obstetric outcomes were also similar between the groups except the duration of labour, which was 6.8hr (SD 1.6) in the experimental group and 5.7hr (SD 1.5) in the control group, mean difference 1.1hr (95% CI 0.2 to 2.0). Patients in both groups were satisfied with the care provided by the physiotherapist. CONCLUSION: Massage reduced the severity of pain in labour, despite not changing its characteristics and location.

Recursos não-farmacológicos no trabalho de parto: protocolo assistencial / Non-pharmacological resources in labor: care protocol

As ações voltadas à humanização do parto e nascimento proporcionam reflexão sobre a assistência obstétrica adotada no passado, quando um menor número de intervenções era realizado. A literatura tem registrado avanços notáveis no conhecimento sobre os recursos não-farmacológicos para o alívio da dor durante o trabalho de parto, proporcionando melhor evolução desta fase, que é um reflexo do maior conforto para a parturiente. O objetivo deste artigo foi propor um protocolo para utilização dos recursos não-farmacológicos para alívio da dor e auxílio na condução do trabalho de parto, com base em evidência científica obtida a partir de revisão da literatura. Foram realizadas buscas nas bases de dasos Scielo, PubMed, PEDro, MedLine, Bireme e Biblioteca Cochrane, e 25 artigos randomizados, controlados e de revisão da literatura foram incluídos. Embasado na avaliação destes estudos, foi elaborado um protocolo assistencial para utilização dos recursos não-farmacológicos no trabalho de parto, ressaltando a importância da atuação interdisciplinar na promoção do parto humanizado.

Actions directed to humanizing delivery and childbirth provide a reflection on the obstetric care adopted in the past, when a smaller number of interventions occurred in those moments. Literature has reported a remarkable progress on the knowledge of non-pharmacological reseources in pain relief during labor, providing a better outcome of this phase, which is a reflection of a bigger comfort for the parturient. The aim of this paper was to propose a care protocol for the use of the various non-pharmacological resources available to relieve pain and to aid in the conduction of labor based on scientific evidences, obtained from a literature review. It was performed a search in the databases of SciELO, PubMed, PEDro, MedLine, Bireme, Cochrane, and 25 randomized, controlled and revision articles were included. Based on the evaluation of these studies, a care protocol was developed to use non-pharmacological resources in labor, emphasizing the importance of interdisciplinary work in the promotion of humanizing delivery.

Avaliçao da doxiciclina como tratamento complemantar da doença inflamatoria pélvica aguda_- Estudo duplo-cego / Evaluation of doxyclycline for the complementary treatment of acute inflamatory pelvic disease.A double-blind study

Os objetivos deste estudo foram: 1) verificar quais sao as complicaçoes da Doença Inflamatória Pélvica Aguda (DIPA) dose meses apos tratamento clínico com penicilina cristalina e cloranfenicol; e 2) avaliar a eficácia do tratamento complementar com doxiciclina (via oral) para evitar recorrencia e formaçao de abscessos em pacientes com DIPA. Estas hipóteses foram testadas em estudo duplo-cego envolvendo 127 pacientes portadoras de DIPA, tratadas com penicilina cristalina e cloranfenicol. O grupo I, composto de 64 mulheres utilizou doxiciclina via oral (200 mg/dia) por dez dias como tratamento complementar. As 63 pacientes restantes compuseram o grupo II (placebo). No grupo I, a taxa de recorrencia de DIPA foi de 3,1 por cento (2 pacientes), sem nenhum caso de abscesso. No grupo II a taxa de recorrencia chegou a 12,7 por cento (8 pacientes), verificando-se que 37,5 por cento delas (3) desenvolveram abscesso pélvico. A análise estatística (Teste Exato de Fisher) mostrou diferenças estatísticamente significativas entre os dois esquemas terapêuticos. O tratamento clínico da DIPA é limitado nos países em desenvolvimento devido ao isolamento bacteriano deficitário, falta de derivados tetraciclínicos injetáveis e alto custo de novos esquemas polivalente de tratamento. Considerando todas estas dificuldade, a combinaçao de penicilina cristalina e cloranfenicol é usada. Esse é um esquema terapêutico de baixo custo, mas de baixa eficácia contra Chlamydia trachomatis, Mycoplasma hominis e Ureaplasma urealyticum. Devido a etiologia polimicrobiana da DIPA, o tratamento complementar com doxiciclina contempla estas exigencias, provando ser efetiva no sentido de evitar recorrencias da síndrome e boa opçao terapêutica em países nao industrializados.